We thus adopted the Johnson-Verhaak nomenclature to label EGFR+ tumor clusters (Fig. 1c,f) with cluster 22 proliferating stem-like cells displaying the most proliferating cells (Fig. 1f). The gene discussed is EGFR; the disease is neoplasm.